ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Income Statement
NASDAQ:ADPT - Nasdaq - US00650F1093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 189.53M | 178.96M | 170.28M | 185.30M | 154.30M | |||
| Minority Interest Expense | 55.00K | 103.00K | 54.00K | 200.00K | 0.00 | |||
| Cost Of Goods | 71.01M | 72.08M | 75.55M | 57.90M | 49.30M | |||
| Gross Profit | 118.52M | 106.88M | 94.72M | 127.40M | 105.00M | |||
| Operating Expenses | 254.71M | 262.22M | 296.33M | 326.00M | 314.00M | |||
| Research and Development | 87.90M | 94.33M | 109.64M | 122.70M | 142.30M | |||
| Selling, General, and Administrative Expenses | 156.09M | 157.56M | 172.51M | 183.20M | 170.00M | |||
| Operating Income | -136.19M | -155.34M | -201.61M | -198.60M | -209.00M | |||
| Interest Income/Expense | 1.50M | 2.95M | 1.73M | -200.00K | 1.70M | |||
| Non Recurring Items | N/A | -7.21M | -25.43M | -1.60M | N/A | |||
| Income Before Taxes | -141.89M | -159.59M | -225.30M | -200.40M | -207.30M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -141.84M | -159.49M | -225.25M | -200.20M | -207.30M | |||
| EBITDA | -117.41M | -136.09M | -179.38M | -177.70M | -195.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.96 | -1.08 | -1.56 | -1.40 | -1.48 | |||
| Non GAAP EPS | -0.96 | -1.09 | -1.38 | -1.41 | -1.47 | |||
| Statistics | ||||||||
| Gross Profit Margin | 62.53% | 59.72% | 55.63% | 68.75% | 68.05% | |||
| Profit Margin | -74.84% | -89.12% | -132.29% | -108.04% | -134.35% | |||
| Operating Profit Margin | -71.86% | -86.81% | -118.40% | -107.18% | -135.45% | |||
All data in USD